| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 15,000 | 0.00 | 0 |
| 4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 28,606 | 104.41 k | 15,000 | |
| 6 Jun 24 | JSPR Jasper Therapeutics | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 25.41 | 7,500 | 190.58 k | 7,500 |
| 1 May 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 43,606 |
| 1 May 24 | RVNC Revance Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.795 | 23,458 | 89.02 k | 23,458 |
| 25 Jan 24 | AVBP ArriVent BioPharma, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 18 | 17,884 | 321.91 k | 17,884 |
